Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Rapid Response Innovation Awards, 2010
    Is glucose metabolism perturbed in PD?

    Objective/Rationale: 
    Glucose metabolism is of central importance in maintaining the anti-oxidant ability of neurons to protect themselves from internal and external damage. When glucose metabolism is...

  • Rapid Response Innovation Awards, 2010
    Immuno-PCR Detection of Alpha-Synuclein Phosphorylated at Serine-129 as PD Biomarker

    Objective/Rationale: 
    At present, the definite diagnosis of PD can be made only after death by examining the pathology in brain of deceased patients. Diagnosis assesses the presence of clumps within...

  • Rapid Response Innovation Awards, 2010
    Increased Dopamine Transporter Function as an Early Phenotype of PD, Prior to Dopamine Neuron Cell Death

    Objective/Rationale: 
    Since the identification of a number of Parkinson’s disease genes in humans, much effort has been spent at developing pre-clinical models of the disease. However, most genetic pre...

  • Novel Hypotheses in Parkinson's Disease, 2010
    Gait disturbances in Parkinson's disease: new links to alpha-synuclein pathology

    Objective/Rationale: 
    Gait disturbances in PD are characteristic of advanced Parkinson’s disease (PD); they are extremely disabling to the patient and can frequently lead to patient falls, fractures...

  • Novel Hypotheses in Parkinson's Disease, 2010
    Identifying and Localizing Toxic Oligomeric A-Syn with Morphology Specific Nanobodies

    Objective/Rationale: 
    Aggregation and deposition of the protein, a-synuclein (a-syn), has been strongly correlated with PD and other related neurodegenerative disorders. The a-syn protein occurs in a...

  • Pharmacodynamic Biomarkers of LRRK2 Activity, 2010
    Determining Pharmacodynamic Biomarkers of LRRK2 Activity in Lymphocytes

    Objective/Rationale: 
    Therapeutic strategies targeting aberrant LRRK2 activity hold great promise for the treatment of familial LRRK2 mutant and perhaps idiopathic PD. Development of pharmacodynamic...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.